This website uses cookies to enhance the user experience.
DR FURST MEDISINSK LABORATORIUM AS

DR FURST MEDISINSK LABORATORIUM AS931 469 851

Laboratory
Limited company
Søren Bulls vei 25 1051 OSLO, Norge

DR FURST MEDISINSK LABORATORIUM AS

Fürst Medisinsk Laboratorium
Primærhelsetjenestens sentrallaboratorium - Norges største

Keywords

x-ray institutesblood banks

Links

Organization

Chairman of the board
Years since formation
29 years
since Feb 19, 1995
Type
Limited company
VAT registered
Yes
Number of employees
36

Ownership

Number of shares and share classes
2,643
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
944,151,385
NOK
Annual total result 2023
114,855,288
NOK
Total equity 2023
44,065,558
NOK
Last update: Sep 12, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member
22.38 %
indirectly
Board Member-
YC
Board Member-
Board Member-
Alternate Member-
Alternate Member-

Others

NameRoleShares
P
PKF REVISJON AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Board Member
22.38 %
indirectly
-
9.9 %
indirectly
-
5.58 %
indirectly
Last update: Jul 9, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
F
FÜRST HOLDING AS
Ordinary shares
2,643
100 %

Shares owned by the DR FURST MEDISINSK LABORATORIUM AS

NameShare classNumber of sharesShare
F
FURST NAT AS
Ordinary shares
2,900
100 %
A
AS MED-LAB
Ordinary shares
9,747
100 %
P
PATOGEN AS
Ordinary shares
666,667
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 62,895,043
    Operating profit 2023: NOK 53,971,451
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
944,151,385
895,497,602
960,733,021
Annual Total Result
114,855,288
65,756,478
80,864,348
Total assets
496,384,657
436,027,325
533,625,404
Total liabilities
452,319,099
395,486,781
447,163,666
Total equity
44,065,558
40,540,545
86,461,738

P&L

Year202320222021
Total operating income
944,151,385
895,497,602
960,733,021
Total operating costs
857,734,623
804,271,825
865,556,515
Operating result
86,416,762
91,225,777
95,176,506
Financial income/costs
44,969,239
-6,987,448
6,003,424
Profit before tax
131,386,001
84,238,329
101,179,930
Total tax & extraordinary income/cost
16,530,713
18,481,851
20,315,582
Annual Total Result
114,855,288
65,756,478
80,864,348

Balance overview

Year202320222021
Total fixed assets
352,624,709
351,841,889
351,643,961
Total current assets
143,759,948
84,185,436
181,981,443
Total assets
496,384,657
436,027,325
533,625,404
Short term debt
214,136,270
128,186,781
148,380,843
Long term debt
238,182,829
267,300,000
298,782,823
Total liabilities
452,319,099
395,486,781
447,163,666
Contributed capital
40,540,545
40,540,545
46,254,399
Retained earnings
3,525,013
0
40,207,339
Total equity
44,065,558
40,540,545
86,461,738
Total equity and liabilities
496,384,657
436,027,325
533,625,404

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.906
Industrial group
Medical laboratories